GETZID MR 60MG TABLET

GETZID MR 60MG TABLET contains Gliclazide as its active ingredient. It belongs to the class of medications known as sulfonylureas, which are oral antidiabetic drugs used to manage type 2 diabetes mellitus.

Mechanism of Action:

Gliclazide works by stimulating the release of insulin from the pancreatic beta cells, thereby increasing insulin secretion. It also enhances the sensitivity of peripheral tissues to insulin, allowing for better utilization of glucose by the body’s cells. This mechanism helps to lower blood glucose levels in patients with type 2 diabetes.

Uses:

GETZID MR 60MG TABLET is indicated for the management of type 2 diabetes mellitus in adults. It is used to control blood sugar levels and reduce the risk of complications associated with diabetes, such as cardiovascular disease, kidney damage, and nerve damage.

Dosage and Administration:

The dosage of GETZID MR 60MG TABLET may vary depending on the individual patient’s condition and response to treatment. It is typically taken orally once daily with breakfast or the first main meal of the day. The tablet should be swallowed whole with a glass of water and not crushed or chewed.

Side Effects:

Common side effects associated with GETZID MR 60MG TABLET may include:

• Hypoglycemia (low blood sugar)
• Nausea
• Vomiting
• Diarrhea
• Abdominal discomfort
• Headache
• Dizziness
• Skin rash or itching

Precautions:

• Patients should be advised to monitor their blood sugar levels regularly while taking GETZID MR 60MG TABLET and to report any symptoms of hypoglycemia or hyperglycemia to their healthcare provider.
• Use caution when driving or operating machinery, as GETZID MR 60MG TABLET may cause dizziness or drowsiness, especially during the initiation of therapy or in combination with other medications.
• Patients with severe liver or kidney impairment may require dose adjustments or close monitoring while taking GETZID MR 60MG TABLET.
• GETZID MR 60MG TABLET should not be used in patients with type 1 diabetes, diabetic ketoacidosis, or severe metabolic disorders.

Conclusion:

GETZID MR 60MG TABLET, containing Gliclazide, is an oral antidiabetic medication used for the management of type 2 diabetes mellitus. By stimulating insulin secretion and improving insulin sensitivity, gliclazide helps to control blood sugar levels and reduce the risk of complications associated with diabetes. However, it is essential to use this medication cautiously and under the guidance of a healthcare professional to minimize the risk of side effects and hypoglycemia.